15.11.2014 Views

download - Malaysian Thoracic Society

download - Malaysian Thoracic Society

download - Malaysian Thoracic Society

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Annual Congress of <strong>Malaysian</strong> <strong>Thoracic</strong> <strong>Society</strong><br />

OP 5<br />

DREV1 Silencing Promotes Cell Proliferation and<br />

Invasion in Lung Adenocarcinoma<br />

Nur Shukriyah Mohamad Hazir 1,4 , Pang Jyh Chyang 1 , Isa Rose 3 , Roslina Abdul Manap 2 ,<br />

Fauzi Anshar 2 , Nor Adina Ahmad Tajudin 2 , Andrea Ban Yu-Lin 2 , Roslan Harun 1,2<br />

1<br />

UKM Medical Molecular Biology Institute (UMBI), 2 Department of Medicine,<br />

3<br />

Department of Pathology, UKM Medical Centre, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia<br />

4<br />

Institute of Medical Science Technology (MESTECH), Universiti Kuala Lumpur, Malaysia<br />

Introduction<br />

We have previously identified that decreased expression of DREV1 was associated with shorter survival in<br />

patients with advanced non-small cell lung cancers (NSCLCs). The exact mechanism how reduction of DREV1<br />

leads to shorter survival is still not known.<br />

Objective<br />

To determine the roles of DREV1 in cancer progression Methods: Quantitative Real Time PCR (qPCR) and<br />

Tissue Microarray Immuno-histochemistry (TMA-IHC) were performed to validate the expression of DREV1.<br />

Silencing of DREV1 was done using DHARMACON SmartPooled Small Interfering RNA (Thermo Scientific)<br />

on the A549 lung adenocarcinoma cell line. Cell viability and apoptosis were measured using CellTiter-<br />

Glo® Luminescent Cell Viability Assay (PROMEGA) and Caspase-Glo® 3/7 Assay (PROMEGA) respectively.<br />

The effect of DREV1 inhibition on cell invasion was studied using QCMTM 24-well Collagen-Based Cell<br />

Invasion Assay–Colorimetric (CHEMICON). The downstream genes and signal cascades were interrogated<br />

using Illumina HumanRef-8 v3.0 Expression BeadChips.<br />

Results<br />

qRT-PCR confirmed that the expression of DREV1 was significantly higher in the long survival group (n=8)<br />

compared to the short survival group (n=8). TMA-IHC showed the DREV1 expression was reduced in<br />

advanced stages of NSCLC (Stage III and IV) compared to the early stages (Stage I and II). Silencing of DREV1<br />

increased cell proliferation, reduced apoptosis through reduction in Caspase 3 and 7 activities and increased<br />

cell invasion. Microarray gene expression analysis revealed that silencing of DREV1 activated SRC, GNAQ<br />

and PIK3R, mediators of PAR1 and PKY2/ERK/MAPK pathway that promotes proliferation, migration and cell<br />

invasion.<br />

Conclusions<br />

Reduced expression of DREV1 may contribute to poor survival in NSCLCs through increased cancer cell<br />

proliferation and cell invasion, and reduced apoptosis.<br />

52

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!